Ann: Epsilon Enters Exclusive Partnership with The Valens Company, page-37

Yep up in Smoke

Nothing in Valens Meets the requirements. So long wait and Clinical Trials, Cash, Cash 12 months plus
Per Sydney Morning Herald
In February, the country’s medicines regulator - the Therapeutic Goods Administration (TGA) - agreed to change the classification for certain products containing small amounts of cannabidiol (CBD), an active ingredient in the cannabis plant that does not get the user high but is used in therapeutic products.

Under the new rules, cannabis medicines in this category are classified as “schedule 3” medicines and can be sold in pharmacies without the need for a prescription. However, no Australian products currently fit the criteria for an over-the-counter medicine, meaning drug developers must set up clinical trials for new products and show that they work before anything can be sold to consumers.
Nice to see all the threads again and posters interesting Lesson for all New and updates